Search Results

Your search for Robert Peter Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCPI(hon), FRSM matches 2 pages

Showing 1 - 2

By Robert Peter Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCPI(hon), FRSM; Rüdiger Hehlmann, MD, PhD; and Andreas Hochhaus, MD / March 25, 2020

AML Pioneer and Giant, Clara D. Bloomfield, MD, FASCO, Dies at 77

Physicians and scientists interested in acute myeloid leukemia (AML) have lost one of the community’s shining lights with the death of Clara D. Bloomfield, MD, FASCO, on March 1, 2020, at age 77 years. Dr. Bloomfield is well known for her more than 50 years of groundbreaking research in blood...

issues in oncology

By Robert Peter Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCPI(hon), FRSM, and David G. Nathan, MD / July 25, 2019

Physicians and the Threat of Nuclear War

The Hippocratic Oath calls on physicians to “use treatment to help the sick according to my ability and judgment,” but not all versions of the oath call on us to prevent disease. Here we urge our colleagues to acknowledge that additional mandate and renew their commitment to preventing what could ...

Nov

Today In Oncology

Search Results

Your search for Robert Peter Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCPI(hon), FRSM matches 2 pages

AML Pioneer and Giant, Clara D. Bloomfield, MD, FASCO, Dies at 77

Physicians and the Threat of Nuclear War

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC